Toes-Zoutendijk E. Interval cancers after a negative faecal immunochemical test in the first screening round in the Netherlands: results for two cut-off levels. UEG Week 2018, LB14.
Epcoritamab en tislelizumab in de sluis geplaatst
nov 2023 | Lymfoom, Maag-darm-leveroncologie